Daliresp 500 MCG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJ5EN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,257
Award facts
- Contract value 100% obligated
- $22,257.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $22,257.25 delivery order to AmerisourceBergen Drug Corp for Daliresp 500 mcg tablets (90-count supply) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The award was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems through its extensive portfolio of delivery orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The DLA Troop Support Medical contract enables the company to supply pharmaceutical products supporting military healthcare programs globally and serves multiple government healthcare customers, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Daliresp—a medication used to treat chronic obstructive pulmonary disease—reflects the routine pharmaceutical resupply operations conducted under the larger IDC framework.
Quick answers
Who was awarded contract SPE2DB25FJ5EN?
SPE2DB25FJ5EN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FJ5EN worth?
The government has obligated $22,257 on SPE2DB25FJ5EN.
Is contract SPE2DB25FJ5EN an order under another contract?
Yes. SPE2DB25FJ5EN is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5EN competed?
The extent of competition for SPE2DB25FJ5EN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award